Novo Nordisk already has a pill form of semaglutide that is used for diabetes
In May 2026, the Centers for Medicare & Medicaid Services (CMS) announced a major new effort to improve access to high-cost weight-loss medications for older Americans
Respiratory enzymes in oxidative phosphorylation
Where the research should go next Key open questions include how much endogenous GLP1 increase is needed for sustained weight change, whether combinations of diet, prebiotics, probiotics and nutraceuticals can match injectable outcomes, and the longterm safety of such combinations
Absorption and bioavailability Semaglutide breaks down quickly in stomach acid, so oral tablets use a special absorption technology called salcaprozate sodium (SNAC)
Once it receives FDA approval, it will likely be prescribed as a once-weekly injection, much like other medications in the GLP-1 agonist class